At KSQ Therapeutics, we are always looking for strong leaders to join our team.
Contact us about current job opportunities.
To be able to manage our flow of candidates we do not accept unsolicited resumes from any source other than directly from the candidates for current or future positions. Submission of unsolicited referrals and/or resumes in advance of a signed agreement between KSQ and the recruiter are deemed gratuitous and KSQ will not be obligated or bound in any way to pay any referral or other fees if such person is hired. Thank you in advance for your adherence to our process. For any hiring needs, please contact us.
KSQ Therapeutics, Inc. has an immediate opening for an Associate Director / Director, Medicinal Chemistry position in Cambridge, MA. KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is advancing a proprietary pipeline of tumor- and immune-focused drug candidates for oncology. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies. The company is located in Kendall Square in Cambridge, Massachusetts.
KSQ Therapeutics is seeking an exceptional, innovative and highly motivated Principal Scientist / Associate Director: Medicinal Chemistry to apply fundamentals of synthesis, SAR and structure-based design toward the optimization of chemical matter to advance our portfolio of drug development programs. This person will contribute to the company’s emerging NCE drug design organization and participate scientifically to build a strong portfolio of novel drug candidates. As part of the team of scientists at KSQ Therapeutics, this individual will have responsibility for biological data interpretation, design of molecules, and development of structure-activity relationship as well as execution of the synthetic plan in collaboration with CRO partners. As part of a lead progression team, this individual will set the small molecule drug discovery strategy on one or more programs from hit triaging, hit-to-lead and lead optimization to deliver drug candidates that benefit patients’ lives. The successful individual will join a dynamic, enthusiastic, interdisciplinary, and collaborative team of scientists.